Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:FTHF NASDAQ:GNOM NYSEARCA:NXTE NASDAQ:SARK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTHFFirst Trust Emerging Markets Human Flourishing ETF$26.36-0.7%$25.40$20.03▼$27.09$46.13M1.031,276 shs84 shsGNOMGlobal X Genomics & Biotechnology ETF$8.85-1.9%$8.13$6.80▼$11.88$46.82M1.0362,091 shs43,822 shsNXTEAXS Green Alpha ETF$35.11-0.9%$32.83$25.45▼$35.66$47.05M1.63,729 shs3,685 shsSARKTradr 1X Short Innovation Daily ETF$34.70+1.8%$41.44$27.86▼$132.54$46.50M-1.62286,384 shs169,287 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTHFFirst Trust Emerging Markets Human Flourishing ETF-0.08%-2.03%+2.63%+21.02%+8.04%GNOMGlobal X Genomics & Biotechnology ETF-0.11%+3.20%+6.24%+19.31%-15.07%NXTEAXS Green Alpha ETF+0.43%+1.11%+5.98%+25.54%+3.40%SARKTradr 1X Short Innovation Daily ETF-1.64%-3.51%-15.00%-39.51%-61.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFTHFFirst Trust Emerging Markets Human Flourishing ETFN/AN/AN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ANXTEAXS Green Alpha ETFN/AN/AN/AN/AN/AN/AN/AN/ASARKTradr 1X Short Innovation Daily ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTHFFirst Trust Emerging Markets Human Flourishing ETF 0.00N/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETF 2.67Moderate Buy$8.85N/ANXTEAXS Green Alpha ETF 2.58Moderate Buy$35.11N/ASARKTradr 1X Short Innovation Daily ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTHFFirst Trust Emerging Markets Human Flourishing ETFN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/ANXTEAXS Green Alpha ETFN/AN/AN/AN/AN/AN/ASARKTradr 1X Short Innovation Daily ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTHFFirst Trust Emerging Markets Human Flourishing ETFN/AN/A11.94∞N/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A-$2.34N/A∞N/AN/AN/AN/AN/ANXTEAXS Green Alpha ETFN/AN/A27.52∞N/AN/AN/AN/AN/ASARKTradr 1X Short Innovation Daily ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFTHFFirst Trust Emerging Markets Human Flourishing ETF$0.732.77%N/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/ANXTEAXS Green Alpha ETF$0.100.28%N/AN/AN/ASARKTradr 1X Short Innovation Daily ETF$6.5118.76%N/AN/AN/ALatest FTHF, SARK, GNOM, and NXTE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/26/2025GNOMGlobal X Genomics & Biotechnology ETF$0.00836/27/20256/27/20257/7/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTHFFirst Trust Emerging Markets Human Flourishing ETFN/AGNOMGlobal X Genomics & Biotechnology ETF56.95%NXTEAXS Green Alpha ETFN/ASARKTradr 1X Short Innovation Daily ETFN/AInsider OwnershipCompanyInsider OwnershipFTHFFirst Trust Emerging Markets Human Flourishing ETFN/AGNOMGlobal X Genomics & Biotechnology ETF5.89%NXTEAXS Green Alpha ETFN/ASARKTradr 1X Short Innovation Daily ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFTHFFirst Trust Emerging Markets Human Flourishing ETFN/A1.75 millionN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A5.29 millionN/AOptionableNXTEAXS Green Alpha ETFN/A1.34 millionN/ANot OptionableSARKTradr 1X Short Innovation Daily ETFN/A1.34 millionN/AOptionableFTHF, SARK, GNOM, and NXTE HeadlinesRecent News About These CompaniesTradr 1X Short Innovation Daily ETF (NASDAQ:SARK) Stock Price Down 0.6% - Here's WhyJuly 5, 2025 | americanbankingnews.comTradr 2X Short TSLA Daily ETF Short Interest Report | NASDAQ:TSLQ | BenzingaApril 24, 2025 | benzinga.comTradr 2X Short Innovation Daily ETFApril 4, 2025 | morningstar.comMTop Performing Leveraged/Inverse ETFs: 03/16/2025March 19, 2025 | etftrends.comETop Performing Leveraged/Inverse ETFs: 03/02/2025March 5, 2025 | etftrends.comETop Performing Leveraged/Inverse ETFs: 02/23/2025February 25, 2025 | etftrends.comELearn to Evaluate (SARK) using the ChartsJanuary 17, 2025 | news.stocktradersdaily.comN(SARK) Investment ReportDecember 17, 2024 | news.stocktradersdaily.comN(SARK) Trading SignalsDecember 6, 2024 | news.stocktradersdaily.comN(SARK) Pivots Trading Plans and Risk ControlsNovember 15, 2024 | news.stocktradersdaily.comN(SARK) Technical DataNovember 5, 2024 | news.stocktradersdaily.comN(SARK) Proactive StrategiesOctober 14, 2024 | news.stocktradersdaily.comNInvestment Managers Series Trust II - Tradr 2X Long Triple Q Quarterly ETFOctober 3, 2024 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long SPY Quarterly ETFOctober 3, 2024 | money.usnews.comWhen (SARK) Moves Investors should ListenSeptember 23, 2024 | news.stocktradersdaily.comNSPYB Tradr 2X Long SPY Weekly ETFSeptember 18, 2024 | seekingalpha.comTradr 2X Long SOXX Weekly ETF (SOXW)September 11, 2024 | investing.comTradr 2X Long SPY Weekly (SPYB)September 11, 2024 | investing.comInvestment Managers Series Trust II - Tradr 2X Long SPY Weekly ETFSeptember 5, 2024 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long SOXX Monthly ETFSeptember 5, 2024 | money.usnews.comMedia Sentiment Over TimeFTHF, SARK, GNOM, and NXTE Company DescriptionsFirst Trust Emerging Markets Human Flourishing ETF NYSEARCA:FTHF$26.36 -0.18 (-0.68%) As of 04:10 PM EasternThe First Trust Emerging Markets Human Flourishing ETF (FTHF) is an exchange-traded fund that is based on the Emerging Markets Human Flourishing index. The fund tracks a market cap-weighted index of large- and mid-sized emerging market companies that adequately promotes human flourishing. Securities are screened on their human rights beliefs and are selected based on their fundamentals. FTHF was launched on Oct 30, 2023 and is issued by First Trust.Global X Genomics & Biotechnology ETF NASDAQ:GNOM$8.85 -0.17 (-1.88%) Closing price 03:59 PM EasternExtended Trading$8.93 +0.08 (+0.95%) As of 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.AXS Green Alpha ETF NYSEARCA:NXTE$35.11 -0.33 (-0.93%) As of 04:10 PM EasternThe Axs Green Alpha ETF (NXTE) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively seeks long-term capital appreciation by targeting global all-cap companies focused towards a sustainable environment and economy. Securities are selected based on their contribution to the four pillars of sustainability, whilst exhibiting both growth and value characteristics. NXTE was launched on Sep 27, 2022 and is managed by AXS Investments.Tradr 1X Short Innovation Daily ETF NASDAQ:SARK$34.70 +0.60 (+1.76%) Closing price 04:00 PM EasternExtended Trading$34.72 +0.02 (+0.06%) As of 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AXS Short Innovation Daily ETF (SARK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed fund that seeks to achieve -1x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions. SARK was launched on Nov 9, 2021 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Chipotle: Too Spicy for Smart Money to Resist After Stock Split Plug Power’s 20% Surge Signals New Commercial Growth Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
